Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion

Michael A. Zimmerman, Eunyoung Tak, Stefan F. Ehrentraut, Maria Kaplan, Antasia Giebler, Tingting Weng, Doo Sup Choi, Michael R. Blackburn, Igal Kam, Holger K. Eltzschig, Almut Grenz

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality of hepatic surgery and during liver transplantation. Previous studies implicated extracellular adenosine signaling in liver protection. Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia. During orthotopic liver transplantation in humans, we observed higher expressional levels of ENT1 than ENT2, in conjunction with repression of ENT1 and ENT2 transcript and protein levels following warm ischemia and reperfusion. Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion. Studies in gene-targeted mice for Ent1 or Ent2 demonstrated selective protection from liver injury in Ent1-/- mice. Treatment with selective adenosine receptor antagonists indicated a contribution of Adora2b receptor signaling in ENT-dependent liver protection. Conclusion: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury.

Original languageEnglish (US)
Pages (from-to)1766-1778
Number of pages13
JournalHepatology
Volume58
Issue number5
DOIs
StatePublished - Nov 2013

Fingerprint

Equilibrative Nucleoside Transporter 1
Adenosine
Reperfusion
Ischemia
Nucleoside Transport Proteins
Liver
Liver Transplantation
Wounds and Injuries
Purinergic P1 Receptor Antagonists
Warm Ischemia
Dipyridamole
Reperfusion Injury

ASJC Scopus subject areas

  • Hepatology

Cite this

Zimmerman, M. A., Tak, E., Ehrentraut, S. F., Kaplan, M., Giebler, A., Weng, T., ... Grenz, A. (2013). Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. Hepatology, 58(5), 1766-1778. https://doi.org/10.1002/hep.26505

Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. / Zimmerman, Michael A.; Tak, Eunyoung; Ehrentraut, Stefan F.; Kaplan, Maria; Giebler, Antasia; Weng, Tingting; Choi, Doo Sup; Blackburn, Michael R.; Kam, Igal; Eltzschig, Holger K.; Grenz, Almut.

In: Hepatology, Vol. 58, No. 5, 11.2013, p. 1766-1778.

Research output: Contribution to journalArticle

Zimmerman, MA, Tak, E, Ehrentraut, SF, Kaplan, M, Giebler, A, Weng, T, Choi, DS, Blackburn, MR, Kam, I, Eltzschig, HK & Grenz, A 2013, 'Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion', Hepatology, vol. 58, no. 5, pp. 1766-1778. https://doi.org/10.1002/hep.26505
Zimmerman, Michael A. ; Tak, Eunyoung ; Ehrentraut, Stefan F. ; Kaplan, Maria ; Giebler, Antasia ; Weng, Tingting ; Choi, Doo Sup ; Blackburn, Michael R. ; Kam, Igal ; Eltzschig, Holger K. ; Grenz, Almut. / Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. In: Hepatology. 2013 ; Vol. 58, No. 5. pp. 1766-1778.
@article{95eefc78efca4fcdab19aa441e32757e,
title = "Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion",
abstract = "Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality of hepatic surgery and during liver transplantation. Previous studies implicated extracellular adenosine signaling in liver protection. Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia. During orthotopic liver transplantation in humans, we observed higher expressional levels of ENT1 than ENT2, in conjunction with repression of ENT1 and ENT2 transcript and protein levels following warm ischemia and reperfusion. Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion. Studies in gene-targeted mice for Ent1 or Ent2 demonstrated selective protection from liver injury in Ent1-/- mice. Treatment with selective adenosine receptor antagonists indicated a contribution of Adora2b receptor signaling in ENT-dependent liver protection. Conclusion: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury.",
author = "Zimmerman, {Michael A.} and Eunyoung Tak and Ehrentraut, {Stefan F.} and Maria Kaplan and Antasia Giebler and Tingting Weng and Choi, {Doo Sup} and Blackburn, {Michael R.} and Igal Kam and Eltzschig, {Holger K.} and Almut Grenz",
year = "2013",
month = "11",
doi = "10.1002/hep.26505",
language = "English (US)",
volume = "58",
pages = "1766--1778",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion

AU - Zimmerman, Michael A.

AU - Tak, Eunyoung

AU - Ehrentraut, Stefan F.

AU - Kaplan, Maria

AU - Giebler, Antasia

AU - Weng, Tingting

AU - Choi, Doo Sup

AU - Blackburn, Michael R.

AU - Kam, Igal

AU - Eltzschig, Holger K.

AU - Grenz, Almut

PY - 2013/11

Y1 - 2013/11

N2 - Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality of hepatic surgery and during liver transplantation. Previous studies implicated extracellular adenosine signaling in liver protection. Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia. During orthotopic liver transplantation in humans, we observed higher expressional levels of ENT1 than ENT2, in conjunction with repression of ENT1 and ENT2 transcript and protein levels following warm ischemia and reperfusion. Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion. Studies in gene-targeted mice for Ent1 or Ent2 demonstrated selective protection from liver injury in Ent1-/- mice. Treatment with selective adenosine receptor antagonists indicated a contribution of Adora2b receptor signaling in ENT-dependent liver protection. Conclusion: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury.

AB - Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality of hepatic surgery and during liver transplantation. Previous studies implicated extracellular adenosine signaling in liver protection. Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia. During orthotopic liver transplantation in humans, we observed higher expressional levels of ENT1 than ENT2, in conjunction with repression of ENT1 and ENT2 transcript and protein levels following warm ischemia and reperfusion. Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion. Studies in gene-targeted mice for Ent1 or Ent2 demonstrated selective protection from liver injury in Ent1-/- mice. Treatment with selective adenosine receptor antagonists indicated a contribution of Adora2b receptor signaling in ENT-dependent liver protection. Conclusion: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury.

UR - http://www.scopus.com/inward/record.url?scp=84887023609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887023609&partnerID=8YFLogxK

U2 - 10.1002/hep.26505

DO - 10.1002/hep.26505

M3 - Article

C2 - 23703920

AN - SCOPUS:84887023609

VL - 58

SP - 1766

EP - 1778

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -